Cargando…
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
BACKGROUND: Liposarcoma (LPS) is a tumor derived from adipose tissue, and has the highest incidence among soft tissue sarcomas. Dedifferentiated liposarcoma (DDLPS) is a malignant tumor with poor prognosis. Recurrence and metastasis rates in LPS remain high even after chemotherapy and radiotherapy f...
Autores principales: | Jo, Eun Byeol, Lee, Young Sang, Lee, Hyunjoo, Park, Jae Berm, Park, Hyojun, Choi, Yoon-La, Hong, Doopyo, Kim, Sung Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534902/ https://www.ncbi.nlm.nih.gov/pubmed/31126284 http://dx.doi.org/10.1186/s12885-019-5713-2 |
Ejemplares similares
-
Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma
por: Jo, Eun Byeol, et al.
Publicado: (2018) -
Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness
por: Yoo, Yongjin, et al.
Publicado: (2021) -
Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening
por: Rhu, Jinsoo, et al.
Publicado: (2017) -
CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen
por: Lee, Sanghoon, et al.
Publicado: (2014) -
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)